Skip to main content
logo
TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.060
+0.040 (1.98%)
Jul 23, 2026, 4:00 PM EDT - Market closed

TherapeuticsMD Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.353.021.761.369.962.57
Revenue Growth
82.13%71.61%35.25%-98.14%2619.12%-96.03%
Gross Profit
3.353.021.761.368.571.17
Operating Income
-1.56-4.39-6.11-8.521.19-79.58
Net Income
0.18-0.57-2.18-10.28112-172.42
Earnings Per Share
0.01-0.05-0.19-0.7411.96-9.96
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
8.427.485.064.3338.0764.91
Total Debt
4.825.125.546.537.37196.33
Net Cash (Debt)
3.62.36-0.48-2.2130.7-131.43
Net Cash Growth
------
Net Cash Per Share
0.310.20-0.04-0.213.28-16.51

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
2.72.451.17-23.089.36-55.13
Capital Expenditures
------0.03
Free Cash Flow
2.72.451.17-23.089.36-55.17
Free Cash Flow Growth
28.65%109.74%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%98.00%45.51%
Operating Margin
-46.44%-145.27%-347.08%-654.61%1.70%-3092.77%
Pretax Margin
3.52%-21.61%-133.05%-594.62%1.54%-3082.20%
Profit Margin
2.56%-21.61%-131.29%-591.32%1.54%-3082.20%
FCF Margin
80.50%81.20%66.44%-1772.73%13.38%-2144.07%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
277.25---0.47-
Forward PE
-25.0925.0925.09--
P/FCF Ratio
8.927.698.48-5.67-
PS Ratio
7.116.245.6319.930.7660.15